News & Analysis

Analysts grill Lilly execs on strategy after setbacks

October 21, 2010
J.K. Wall
Wall Street analysts on Thursday demanded to know what new things Eli Lilly and Co. is planning since the company’s vaunted pipeline has failed to produce a drug that will boost revenue after a wave of patent expirations. The answer: Not much.
More

Vera Bradley shares off to impressive start

October 21, 2010
Stock in the Fort Wayne-based company began trading Thursday morning at $16 but climbed as high as $23.90.
More

IU offering master’s degree in event tourism

October 21, 2010
Scott Olson
The Indiana University School of Physical Education and Tourism Management at IUPUI will begin accepting students for the program next fall. The chairman of the school says the new degree fits well with Indianapolis' mission to be a convention destination.
More

Home Health Depot acquires Arcadia subsidiary

October 21, 2010
The division purchased by Home Health Depot markets and sells home health related items via mail and online. Terms of the deal were not disclosed.
More

ITT profit soars despite drop in new-student enrollment

October 21, 2010
J.K. Wall
ITT Educational Services Inc.’s third-quarter profit of $93.2 million handily beat the expectations of Wall Street analysts, but the company suffered its first decline in new-student enrollment since the recession began.
More

Lilly raises forecast after beating third-quarter profit estimates

October 21, 2010
J.K. Wall
The Indianapolis-based drugmaker reported a profit of $1.3 billion in the quarter ended Sept. 30, up 38 percent compared with last year. Excluding extraordinary items from a year ago, Lilly’s profit was up 2 percent.
More

USA Track & Field hit with wrongful termination suit

October 20, 2010
Associated Press
Former USA Track and Field CEO Doug Logan filed a wrongful termination lawsuit against the governing body Wednesday, seeking payment after suddenly being fired last month following a 26-month tenure.
More

Lilly suspends clinical trials after diabetes treatment fails

October 20, 2010
Bloomberg News
Eli Lilly and Co. and its development partner said an experimental diabetes treatment failed to help patients in a late-stage study, the second setback for a Lilly diabetes drug candidate in two days.
More

Indiana agency paying law firm $5.25M to sue IBM

October 20, 2010
Associated Press
Barnes & Thornburg of Indianapolis was hired despite several conflicts of interest arising from the fact that it also represents former IBM partners involved in the welfare deal.
More

Canadian company plans to create 175 jobs in Miami County

October 20, 2010
Conforce International Inc., a manufacturer of composite flooring systems for the transportation industry, plans to invest more than $13.8 million to purchase and equip a plant in Peru, which would be the company's first location in the United States.
More

State getting $25M to clean up old GM sites

October 20, 2010
 IBJ Staff and Associated Press
Indiana will benefit from a $25.2 million environmental trust established to clean up and redevelop eight former General Motors plants throughout the state, officials said Wednesday.
More

Investors brace for ITT's plan to survive new regulations

October 20, 2010
J.K. Wall
The Carmel-based for-profit educator stands to suffer a bigger impact than its peers from new regulations proposed by the U.S. Department of Education, which have already forced the industry behemoth to slash its forecasts.
More

Corporations champion FFA’s mission

October 20, 2010
Scott Olson
The organization's annual convention, which runs Wednesday through Saturday, attracted 375 exhibitors, an impressive number considering the tepid economy.
More

New 'Superman' fellowship hoping to start local charter schools

October 20, 2010
J.K. Wall
Playing off the new education reform documentary “Waiting for ‘Superman,’” the GEO Foundation is using a $100,000 grant to fund a fellowship to launch charter schools in Indianapolis.
More

City rolls out revised parking-meter deal

October 20, 2010
Francesca Jarosz
City would reap more cash in the long run and get more flexibility to alter the deal if necessary, but the controversial 50-year term of the contract remains.
More

UPDATE: Lilly, others see stock slide after drug rejection

October 20, 2010
Bloomberg News
Stock in Eli Lilly and Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. dropped after they were rebuffed a second time in a bid to gain U.S. approval of a once-weekly version of the diabetes drug Byetta.
More

M&I Bank names new Indiana president

October 20, 2010
 IBJ Staff
Tim Massey, who has been head of commercial banking, replaces Reagan Rick, who was promoted to a regional management position.
More

Vera Bradley set to go public

October 20, 2010
Scott Olson
The Fort Wayne-based company is scheduled to begin trading as a public company Wednesday morning. The estimated offering price is $14 to $16 each, although a Morningstar analyst predicts the IPO could bring as much as $18 a share.
More

'Payer mix' playing role in hospital merger

October 20, 2010
J.K. Wall
Morgan Hospital & Medical Center is on the brink of merging with Clarian Health for a variety of reasons, but one of the biggest is one that all hospitals are facing in one way or another: a declining payer mix.
More

Some Lilly-paid docs sport spotty records

October 20, 2010
J.K. Wall
Eli Lilly and Co. paid more than $102 million last year and early this year to physicians for talking up Lilly drugs to other doctors. Yet 88 of the doctors Lilly pays have been sanctioned by state medical boards.
More

Q&A

October 20, 2010
J.K. Wall

Amy Zucker is president of Indianapolis-based Synergy Marketing Group. Her firm was recently hired by Indianapolis-based ImmuneWorks Inc. to use a new website and search engine optimization to help recruit patients for a Phase 1 trial of ImmuneWorks experimental medicine idiopathic pulmonary fibrosis. The Web strategy is a new wrinkle on patient recruitment—in addition to the traditional partnerships with disease specialists at academic medical centers—that Zucker hopes leads to lower costs and faster clinical trials. Phase 1 clinical trials cost nearly $16,000 per patient.

More

Principal Financial shift to result in local layoffs

October 20, 2010
 IBJ Staff
Financial giant Principal Financial Group Inc. is exiting the health insurance business, a move that will cost 60 Indianapolis workers their jobs.
More

Indiana couple accuses Bank of America of racketeering

October 20, 2010
Bloomberg News
Dwayne Ransom Davis and Melisa Davis accuse the lender of using “robo-signers,” people who sign affidavits attesting to facts underlying foreclosures without actual knowledge of those facts, to push through paperwork to take their home in Knightstown.
More

FDA demands more tests on new Lilly diabetes drug

October 19, 2010
J.K. Wall
Eli Lilly and Co. will have to wait at least 18 months and conduct more studies before it wins market approval of a once-weekly version of diabetes drug Byetta, a potential billion-dollar drug.
More

ISO chooses young maestro Urbanski as director

October 19, 2010
Kathleen McLaughlin
Krzysztof Urbanski, 28, has been named the seventh music director in the Indianapolis Symphony Orchestra's 80-year-history.
More
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT